Quality of life without toxicity or symptoms analysis of a randomized controlled clinical trial comparing efficacy of cabazitaxel versus docetaxel in recurrent head and neck cancer

Quality of life without toxicity or symptoms analysis of a randomized controlled clinical trial comparing efficacy of cabazitaxel versus docetaxel in recurrent head and neck cancer

Background: This analysis was done with the aim to study the overall impact of docetaxel and cabazitaxel treatment using quality-adjusted time without symptoms and toxicity (QTWiST) analysis in head and neck cancer patients receiving second-line treatment. Methods: Overall survival (OS) was partitio...

Full description

Bibliographic Details
Main Authors: Vijay Patil, Amit Joshi, Vanita Noronha, Sachin Dhumal, Arun Chandrasekharan, Nikhil Pande, Sameer Shrirangwar, Anup Toshniwal, Siddharth Turkar, Kushal Gupta, Vikas Talreja, Abhishek Mahajan, Shashikant Juvekar, Atanu Bhattacharjee, Kumar Prabhash
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Cancer Research, Statistics, and Treatment
Subjects:
cabazitaxel
docetaxel
head and neck cancer
quality of life
quality of life without toxicity or symptoms
Online Access:http://www.crstonline.com/article.asp?issn=2590-3233;year=2018;volume=1;issue=1;spage=46;epage=50;aulast=

Internet

http://www.crstonline.com/article.asp?issn=2590-3233;year=2018;volume=1;issue=1;spage=46;epage=50;aulast=

Similar Items